Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus fentanyl versus ketamine plus fentanyl for sedation during colonoscopy
IRCT20170805035510N5Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dexmedetomidine, fentanyl and ketamine in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Relaxation and Pain. Started Apr 2018; status: completed.
02
Drugs
dexmedetomidinefentanylketamine
Beyond the preview
Go deeper on IRCT20170805035510N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170805035510N5.